Greenway L. Schond's Insider Trades & SAST Disclosures

Greenway L. Schond's most recent trade in Mind Medicine Inc was a trade of 5,560 Common Shares done at an average price of $9.8 . Disclosure was reported to the exchange on March 25, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Mind Medicine Inc
Schond L. Greenway Chief Financial Officer 25 Mar 2024 5,560 211,057 - 9.8 54,377 Common Shares
Mind Medicine Inc
Greenway L. Schond Chief Financial Officer 27 Feb 2024 150,000 150,000 - - Stock Option (Right to Buy)
Avalo Therapeutics Inc
Schond L. Greenway CFO Purchase of securities on an exchange or from another person at price $ 1.57 per share. 10 Dec 2021 2,231 3,883 - 1.6 3,503 Common Stock
Avalo Therapeutics Inc
Schond L. Greenway CFO Purchase of securities on an exchange or from another person at price $ 2.68 per share. 10 Jun 2021 652 1,652 - 2.7 1,747 Common Stock
Avalo Therapeutics Inc
Schond L. Greenway CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2021 500,000 500,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades